Bismuth Tripotassium Dicitrate is used for the treatment of gastric and duodenal ulcers, as well as compound ulcers, multiple ulcers, anastomotic ulcers and erosive gastritis.
Bismuth Tripotassium Dicitrate Market contains market size and forecasts of Bismuth Tripotassium Dicitrate in global, including the following market information:
- Global Bismuth Tripotassium Dicitrate Market Revenue, 2017-2022, 2023-2028, ($ millions)
- Global Bismuth Tripotassium Dicitrate Market Sales, 2017-2022, 2023-2028, (K Units)
- Global top five Bismuth Tripotassium Dicitrate companies in 2021 (%)
The global Bismuth Tripotassium Dicitrate market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
- The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
- Tablet Segment to Reach $ Million by 2028, with a % CAGR in next six years.
- The global key manufacturers of Bismuth Tripotassium Dicitrate include Astellas Pharma, Reliable-1 Labs, SAN FEGAN, Sihuan Pharmaceutical, Jichuan Pharmaceutical, Hunan Fangsheng, Livzon Pharm and Suzhou Dongrui Pharmacy, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
- surveyed the Bismuth Tripotassium Dicitrate manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Bismuth Tripotassium Dicitrate Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Bismuth Tripotassium Dicitrate Market Segment Percentages, by Type, 2021 (%)
Global Bismuth Tripotassium Dicitrate Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Bismuth Tripotassium Dicitrate Market Segment Percentages, by Application, 2021 (%)
- Stomach Ulcer
- Irritable Bowel Syndrome
- Functional Dyspepsia
- Others
Global Bismuth Tripotassium Dicitrate Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Bismuth Tripotassium Dicitrate Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Bismuth Tripotassium Dicitrate revenues in global market, 2017-2022 (Estimated), ($ millions)
- Key companies Bismuth Tripotassium Dicitrate revenues share in global market, 2021 (%)
- Key companies Bismuth Tripotassium Dicitrate sales in global market, 2017-2022 (Estimated), (K Units)
- Key companies Bismuth Tripotassium Dicitrate sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Astellas Pharma
- Reliable-1 Labs
- SAN FEGAN
- Sihuan Pharmaceutical
- Jichuan Pharmaceutical
- Hunan Fangsheng
- Livzon Pharm
- Suzhou Dongrui Pharmacy
